Publications

How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia  (2022)

Authors:
Deodato, Marina; Frustaci, Anna Maria; Sportoletti, Paolo; Laurenti, Luca; Murru, Roberta; Visentin, Andrea; Reda, Gianluigi; Mauro, Francesca Romana; Quaresmini, Giulia; Vanazzi, Anna; Vitale, Candida; Orsucci, Lorella; Massaia, Massimo; Sanna, Alessandro; Motta, Marina; Ibatici, Adalberto; Ferrarini, Isacco; Borella, Chiara; Varettoni, Marzia; Tani, Monica; Marinoni, Sara; Ferrario, Andrea; Zamprogna, Giulia; Montillo, Marco; Tedeschi, Alessandra
Title:
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia
Year:
2022
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Referee:
No
Name of journal:
Leukemia and Lymphoma
ISSN of journal:
1042-8194
N° Volume:
63
Number or Folder:
8
Page numbers:
1985-1988
Keyword:
COVID-19; Chronic lymphocytic leukemia; Rituximab; venetoclax
Short description of contents:
Chronic lymphocytic leukemia (CLL) patients diagnosed with severe acute respiratory syndrome coronavirus-2 disease (COVID-19) are at high risk of hospitalization and death independently of disease phase or treatment status. Considering these observations, we collected data from 21 CLL referral centers in Italy to better understand the attitude toward choice and management of venetoclax- based treatment during the pandemic, also in the light of ASH recommendations.
Product ID:
130951
Handle IRIS:
11562/1081769
Last Modified:
May 31, 2023
Bibliographic citation:
Deodato, Marina; Frustaci, Anna Maria; Sportoletti, Paolo; Laurenti, Luca; Murru, Roberta; Visentin, Andrea; Reda, Gianluigi; Mauro, Francesca Romana; Quaresmini, Giulia; Vanazzi, Anna; Vitale, Candida; Orsucci, Lorella; Massaia, Massimo; Sanna, Alessandro; Motta, Marina; Ibatici, Adalberto; Ferrarini, Isacco; Borella, Chiara; Varettoni, Marzia; Tani, Monica; Marinoni, Sara; Ferrario, Andrea; Zamprogna, Giulia; Montillo, Marco; Tedeschi, Alessandra, How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia «Leukemia and Lymphoma» , vol. 63 , n. 82022pp. 1985-1988

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<back
Share